JDS THERAPEUTICS LAUNCHES NEW WEBSITE

JDS THERAPEUTICS LAUNCHES NEW WEBSITE

JDSTherapeutics.com will provide information to Patients and Healthcare Professionals

PURCHASE, NY, June 10, 2013  – JDS Therapeutics, LLC, a marketer of proprietary, high-quality healthcare products to physicians, healthcare-delivery networks, and other healthcare professionals announced today the launch of their new website, www.JDSTherapeutics.com.

The new website will provide information about JDS Therapeutics’ growing suite of marketed and pipeline products that can be used in the management and treatment of various health conditions. With interactive, drop-down menu tabs and a highly functional, easy-to-use interface, users can browse and explore in-depth information about the health benefits of JDS Therapeutics’ high-quality healthcare products.

President and CEO Michael Satow commented, “We are very excited about the launch of our new website, and we expect that it will provide healthcare professionals with valuable information about our products and the health conditions they support.”

About JDS Therapeutics:
JDS Therapeutics markets proprietary, high-quality healthcare products to physicians, healthcare-delivery networks, and other healthcare professionals. JDS is focused on providing patients with scientifically backed, natural approaches to meeting their healthcare needs. JDS Therapeutics owns more than 100 issued patents worldwide involving clinically active natural compounds. JDS was founded in 2011, by Phillip and Michael Satow, a father and son team whose previous company, JDS Pharmaceuticals was sold in 2007 to Noven Pharmaceuticals for $125 million.

For more information, please contact us.